期刊文献+

胰岛素对2型糖尿病患者血清高敏C反应蛋白的影响

下载PDF
导出
摘要 目的:探讨胰岛素对2型糖尿病患者血清中高敏C反应蛋白(hs-CRP)的影响作用。方法:对2006年7月-2007年8月79例2型糖尿病住院患者采用胰岛素治疗,治疗前后测定血清高敏C反应蛋白水平。结果:治疗前患者血清高敏C反应蛋白平均值4.03±4.57mg/dl,治疗后高敏C反应蛋白平均值1.99±2.34mg/dl,治疗后血清高敏C反应蛋白水平明显降低。结论:胰岛素能明显降低血清中高敏C反应蛋白水平,抑制炎症反应,有效预防糖尿病并发症的发生。
作者 关秀军 金进
出处 《数理医药学杂志》 2008年第2期176-177,共2页 Journal of Mathematical Medicine
  • 相关文献

参考文献7

  • 1Volanakis JE. Human C-reactive protein: expression, structure and function. Mollmmunol, 2001,38:189-97.
  • 2Barzilay JI,Abaham I,Heckbert SR,et aL The relation of markers of inflammation to the development to glucose disorders in the elderly: the cardiovascular health study. Diabetes, 2001,50: 2384-2389.
  • 3Pickup DT, Crook MA. Is type 2 diabetes mellitus a disease of the innate immune system? Diabetologia, 1998,41: 1241-1248.
  • 4Festa A, Agostno RD, Howard G, et al. Chronic subclinical inflammation as part to the insulin resistance syndrome. Cirulation, 2001, 102:42-47.
  • 5Pickup JC, Mattock MB,Chusney GD ,et al. NIDDM as a disease of the innate immune system: association of acute phase reactants and interleukin 6 with metabolic syndrome Ⅹ. Diabetologia, 1997,1286-1292.
  • 6吴晓燕,高林,汤旭磊.糖尿病患者血清hs-CRP的测定及临床意义[J].中国老年学杂志,2005,25(1):23-24. 被引量:6
  • 7Yudkin J S ,Panahloo A ,Stehouwer C ,et al. The influence of improvedglycaemic control with insulin and sulphonylureas on acute phase andendothelial markers in Type Ⅱ diabetic subjects. Diabetologia, 2000,43 (9) :1099-1106.

二级参考文献9

  • 1Volanakis JE. Human C-reactive protein: expression, structure, and function [J]. Mol Immunol,2001 ;38:189-97.
  • 2Barzilay JI, Abaham I, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study [J]. Diabetes,2001 ;50:2384-9.
  • 3Pickup DT, Crook MA. Is type 2 diabetes mellitus a diaease of the innate immune system [J] ?Diabetologia, 1998 ;41 : 1241-8.
  • 4Festa A,Agostno RD,Howard G,et al. Chronic subclinical inflammation as part of the insulin resistance syndrome [J]. Circulation, 2001 ; 102 :42-7.
  • 5Ford ES. Body mass index, diabetes, and C-reactive protein among US adults [J]. Diabetes Care,1999;22: 1971-7.
  • 6Pradhan AD, Manson JE, Rifai N,et al. C-reactive protein,interleukin 6,and risk of developing type 2 diabetes mellitus[J]. JAMA,2001:286:327-33.
  • 7Pickup JC, Mattock MB, Chusney GD, et al. NIDDM as a disease of the innate immune system:association of acute phase reactants and interleukin-6 with metabolic syndrome X[J]. Diabetologia,1997 ;40: 286-92.
  • 8Hrnciar J, Gabor D, Hinciarova M, et al . Relation between eytokines (TNF-alpha, IL-1 and 6) and homocysteine in android obesity and the phenomenon of insulin resistance syndromes [ J]. Vnitr Lek, 1999;45(1):11-6.
  • 9Yudkin JS, Stehouwer CD, Emeis JJ, et al . C-reactive protein in healthy subjects :associations with obesity, insulin resistance, and endothelial dysfunction:a potential role for cytokines originating from adipose tissue[J] ? Arterioscler Thromb Vasc Biol, 1999 ; 19 (4) : L972-8.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部